Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nyse
  5. Anthem, Inc.
  6. Summary
    ANTM   US0367521038

ANTHEM, INC.

(ANTM)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/19/2021 07/20/2021 07/21/2021 07/22/2021 07/23/2021 Date
384.44(c) 389.94(c) 383.59(c) 384.3(c) 382.29(c) Last
1 087 387 1 731 200 1 756 894 944 715 881 204 Volume
-2.32% +1.43% -1.63% +0.19% -0.52% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 137 B - -
Net income 2021 6 122 M - -
Net Debt 2021 19 675 M - -
P/E ratio 2021 15,5x
Yield 2021 1,11%
Sales 2022 149 B - -
Net income 2022 6 645 M - -
Net Debt 2022 13 708 M - -
P/E ratio 2022 13,9x
Yield 2022 1,19%
Capitalization 93 208 M 93 208 M -
EV / Sales 2021 0,82x
EV / Sales 2022 0,72x
Nbr of Employees 83 400
Free-Float 99,3%
More Financials
Company
Anthem, Inc. is a health benefits company. The Company operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx and Other. It offers a spectrum of network-based managed care plans to large and small employer, individual, Medicaid and Medicare markets. Its managed care plans include preferred provider organizations; health maintenance organizations; point-of-service plans;... 
More about the company
Ratings of Anthem, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about ANTHEM, INC.
07/24ANTHEM, INC. : Invests in Nearly $90 Million in Affordable Housing in Indiana as..
BU
07/23ANTHEM : Deutsche Bank Adjusts Anthem PT to $408 From $406 on Strong Q2 Results,..
MT
07/22ANTHEM : Strong Q2 Reflects Membership Growth, Below Consensus MLR As RBC Raises..
MT
07/22ANTHEM : Jefferies Adjusts Price Target on Anthem to $453 From $447, Maintains B..
MT
07/22ANTHEM : Mizuho Adjusts Anthem's Price Target to $385 From $380, Maintains Neutr..
MT
07/22ANTHEM : Stephens Adjusts Anthem's Price Target to $440 From $430, Reiterates Ov..
MT
07/22ANTHEM : Price Target From RBC Raised to $408 From $399 After Q2 Beat, 2021 Guid..
MT
07/22ANTHEM : Barclays Adjusts Anthem's Price Target to $450 From $425, Reiterates Ov..
MT
07/22ANTHEM : BMO Capital Adjusts Anthem's Price Target to $465 From $450, Maintains ..
MT
07/22ANTHEM : Cantor Fitzgerald Adjusts Anthem's Price Target to $455 From $430, Reit..
MT
07/21ANTHEM : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
07/21Anthem says COVID-19 costs could rise in coming quarters from variants
RE
07/21Today on Wall Street: Earnings season picks up pace
07/21ANTHEM : Medicaid growth helps insurer Anthem beat Q2 expectations
AQ
07/21US Equities Signal Stronger Session as Futures Climb Pre-Bell; Europe Rallies..
MT
More news
News in other languages on ANTHEM, INC.
07/15Agenda FRANCE & INTERNATIONAL À 7 JOURS
07/14Agenda FRANCE & INTERNATIONAL À 7 JOURS
07/14ANTHEM : Las comunidades hispanas/latinas lideran visitas de telesalud para serv..
06/30ANTHEM, INC. : completa la adquisición de MMM Holdings, LLC y afiliados de Innov..
02/02ANTHEM, INC. : Adquirirá MMM Holdings, LLC y sus Afiliados de InnovaCare Health,..
More news
Analyst Recommendations on ANTHEM, INC.
More recommendations
Chart ANTHEM, INC.
Duration : Period :
Anthem, Inc. Technical Analysis Chart | ANTM | US0367521038 | MarketScreener
Technical analysis trends ANTHEM, INC.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 25
Last Close Price 382,29 $
Average target price 428,39 $
Spread / Average Target 12,1%
EPS Revisions
Managers and Directors
Gail Koziara Boudreaux President, Chief Executive Officer & Director
John Edward Gallina Chief Financial Officer & Executive Vice President
Elizabeth E. Tallett Independent Chairman
Gloria M. McCarthy Chief Administrative Officer & Executive VP
Ramiro G. Peru Independent Director
Sector and Competitors
1st jan.Capi. (M$)
ANTHEM, INC.19.06%93 240
UNITEDHEALTH GROUP18.56%382 152
CIGNA CORPORATION11.86%81 360
HUMANA INC.13.02%56 987
CENTENE CORPORATION22.37%43 064
MOLINA HEALTHCARE, INC.22.81%14 872